HanchorBio - Crunchbase Company Profile & Funding

Q: Where is HanchorBio's headquarters?

HanchorBio is located in Taipei, T'ai-pei, Taiwan.

Q: Who invested in HanchorBio?

HanchorBio has 6 investors including Guangzhou Yuexiu Industrial Investment Fund And Zero2IPO Ventures.

Q: When was the last funding round for HanchorBio?

HanchorBio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has HanchorBio raised to date?

HanchorBio has raised obfuscated.

Overview

HanchorBio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About HanchorBio

CB Rank

19513

HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.

Founded

obfuscation

Public

Series A

Taipei, T'ai-pei, Taiwan

11-50

hanchorbio.com/

Consumer Research

Health Care

Wellness

Funding Rounds

Series A

OBF

obfuscation

Key People

Alvin Luk: President & Chief Medical Officer and Chief Executive Officer (U.S.)
Past Role: HuidaGene Therapeutics, Co-founder and CEO
Scott Liu: Founder, Chief Executive Officer, and Chairman
Past Role: Shanghai Henlius Biotech, Co-Founder & CEO

Details

Legal Name

HanchorBio Inc

Operating Status

Active

Stock Symbol

TSEC:7827.TWO

Company Type

For Profit

Phone Number

+886(0)2-2792-1366

Contact Email

hanchorbio_tw@hanchorbio.com

Predictions & Insights

Growth Insight

See this Growth Insight

HanchorBio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Awards

Products & Services

FBDB™-Based Oncology Therapeutics

A platform for developing biologic drugs with novel modalities targeting cancer and immuno-oncology regulators.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A
obfuscated obfuscation	Series A - HanchorBio	6	obfuscated obfuscation	Sino Biopharmaceutical	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Guangzhou Yuexiu Industrial Investment Fund	—	Series A - HanchorBio	—
Guangzhou Yuexiu Industrial Investment Fund	—	Series A - HanchorBio	—
Guangzhou Yuexiu Industrial Investment Fund	—	Series A - HanchorBio	—
Guangzhou Yuexiu Industrial Investment Fund	—	Series A - HanchorBio	—
Guangzhou Yuexiu Industrial Investment Fund	—	Series A - HanchorBio	—